EP2187882
Meðferð við síversnandi taugahrörnunarsjúkdómi með ibudilast
Status:
EP Einkaleyfi fallið úr gildiEP appl. date:
8.7.2008EP published:
9.1.2013EP application number:
08781498.4
EP translation filed:
30.1.2013Grant published:
15.2.2013EPO information:
European Patent Register
Max expiry date:
7.7.2028Expiry date:
7.7.2014
Title:
TREATMENT OF PROGRESSIVE NEURODEGENERATIVE DISEASE WITH IBUDILAST
Timeline
Today
8.7.2008EP application
9.1.2013EP Publication
30.1.2013Translation submitted
15.2.2013Registration published
7.7.2014Expires
Owner
Name:
MediciNova, Inc.Address:
4350 La Jolla Village Drive, Suite 950, 92122, San Diego, CA, US
Inventor
Name:
KALAFER, Michael, E.Address:
La Jolla, CA, US
Name:
LOCKE, Kenneth, W.Address:
Carlsbad, CA, US
Name:
MATSUDA, KazukoAddress:
Beverly Hills, CA, US
Name:
GAMMANS, Richard, E.Address:
Vass, NC, US
Agent
Name:
Árnason Faktor ehf.Address:
Guðríðarstíg 2-4, 113, Reykjavík,
Priority
Number:
929745 PDate:
11.7.2007Country:
US
Number:
42181Date:
3.4.2008Country:
US
Classification
Categories:
A61K 31/437, A61P 25/28
Annual fees
Number
Paid
Expires
Payer
Number: 6
Paid: 25.6.2013
Expires: 7.7.2014
Payer: Árnason Faktor